Chlamydial Pgp3 Seropositivity and Population-Attributable Fraction Among Women With Tubal Factor Infertility
article
OA: green
CC0
Abstract
BACKGROUND: Chlamydial infection is associated with tubal factor infertility (TFI); however, assessment of prior chlamydial infection and TFI is imperfect. We previously evaluated a combination of serological assays for association with TFI. We now describe the chlamydial contribution to TFI using a newer Chlamydia trachomatis Pgp3-enhanced serological (Pgp3) assay. METHODS: In our case-control study of women 19 to 42 years old with hysterosalpingogram-diagnosed TFI (cases) and non-TFI (controls) in 2 US infertility clinics, we assessed possible associations and effect modifiers between Pgp3 seropositivity and TFI using adjusted odds ratios with 95% confidence intervals (CIs) stratified by race. We then estimated the adjusted chlamydia population-attributable fraction with 95% CI of TFI. RESULTS: All Black (n = 107) and 618 of 620 non-Black women had Pgp3 results. Pgp3 seropositivity was 25.9% (95% CI, 19.3%-33.8%) for non-Black cases, 15.2% (95% CI, 12.3%-18.7%) for non-Black controls, 66.0% (95% CI, 51.7%-77.8%) for Black cases, and 71.7% (95% CI, 59.2%-81.5%) for Black controls. Among 476 non-Black women without endometriosis (n = 476), Pgp3 was associated with TFI (adjusted odds ratio, 2.6 [95% CI, 1.5-4.4]), adjusting for clinic, age, and income; chlamydia TFI-adjusted population-attributable fraction was 19.8% (95% CI, 7.7%-32.2%) in these women. Pgp3 positivity was not associated with TFI among non-Black women with endometriosis or among Black women (regardless of endometriosis). CONCLUSIONS: Among non-Black infertile women without endometriosis in these clinics, 20% of TFI was attributed to chlamydia. Better biomarkers are needed to estimate chlamydia TFI PAF, especially in Black women.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
References (31)
- Endometriosis‐associated infertility: aspects of pathophysiological mechanisms and treatment options via openalex
- Hysterosalpingography in endometriosis: performance and interpretation via openalex
- W2035657519 via openalex
- W2058100734 via openalex
- W2079304777 via openalex
- W2104892711 via openalex
- W2131805980 via openalex
- W2154012337 via openalex
- W2158987406 via openalex
- W2166902271 via openalex
- W2192116738 via openalex
- W2256786579 via openalex
- W2297473547 via openalex
- W2298582365 via openalex
- W2309207579 via openalex
- W2314012327 via openalex
- W2316327782 via openalex
- W2342003420 via openalex
- W2569205179 via openalex
- W2580187317 via openalex
- W2614416295 via openalex
- W2761343559 via openalex
- W2848284079 via openalex
- W2895134825 via openalex
- W2901621035 via openalex
- W2904231896 via openalex
- W2963863201 via openalex
- W7073672577 via openalex
- W1970215763 via openalex
- W7074007065 via openalex
- W1992363311 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:24:37.768885+00:00
License: CC0
· commercial use OK